ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

BACKGROUND: The role and clinical value of ERβ1 expression is controversial and recent data demonstrates that many ERβ antibodies are insensitive and/or non-specific. Therefore, we sought to comprehensively characterize ERβ1 expression across all sub-types of breast cancer using a validated antibody...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Reese, Jordan M, Suman, Vera J, Subramaniam, Malayannan, Wu, Xianglin, Negron, Vivian, Gingery, Anne, Pitel, Kevin S, Shah, Sejal S, Cunliffe, Heather E, McCullough, Ann E, Pockaj, Barbara A, Couch, Fergus J, Olson, Janet E, Reynolds, Carol, Lingle, Wilma L, Spelsberg, Thomas C, Goetz, Matthew P, Ingle, James N, Hawse, John R
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196114/
https://ncbi.nlm.nih.gov/pubmed/25288324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-749
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars